BMC
IDXX icon

Bear Mountain Capital’s Idexx Laboratories IDXX Stock Holding History

Bear Mountain Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10
Closed -$4.78K – 196
2024
Q1 		$4.78K Hold
10
– – ﹤0.01% 143
2023
Q4 		$5.2K Buy
+10
New +$4.7K ﹤0.01% 145

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bear Mountain Capital's IDXX Position: Q2 2024 in Review

Bear Mountain Capital sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 10 shares — an estimated $4.78K sold.

Bear Mountain Capital first reported a position in IDXX in Q4 2023 and held it in 2 quarters. The position peaked at $5.2K in Q4 2023. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Bear Mountain Capital reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • Bear Mountain Capital sold 10 Idexx Laboratories shares in Q2 2024, an estimated $4.78K.
  • Bear Mountain Capital first reported a position in Idexx Laboratories in Q4 2023 and held it in 2 quarters.
  • Bear Mountain Capital's Idexx Laboratories position peaked at $5.2K in Q4 2023.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Bear Mountain Capital's 13F filing for Q2 2024, filed 23 Jul 2024.